[Clinical observation of immunotherapy in ocular malignant tumors with lymphokine-activated killing (LAK) cell].
In this paper, the authors reported the method of treating ocular malignant tumors with lymphokine-activated killing cells which were induced by rIL-2 in vitro. Among the sixteen cases of ocular tumors, 4 cases of 5 base cell carcinoma (1 case of which was partially extinctive), 4 cases of tarsal gland carcinoma, 2 cases of squamous cell carcinoma and respectively 1 case of retinoblastoma, non-Hodgkin's lymphoma, intraorbital hemangiopericytoma, intraorbital fibrous histiocytomas and hidradenocarcinoma were completely extinctive. The result shows that the immunotherapy method is effective.